Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preservation solutions for transplantation.

F Mühlbacher1, F Langer, C Mittermayer

  • 1Chirurgische Universitätsklinik Wien, Abteilung für Transplantation, Austria.

Transplantation Proceedings
|August 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Guide to the application of the 9th TNM classification for lung cancer : Statement/position paper of the Thoracic Pathology Working Group].

Pathologie (Heidelberg, Germany)·2025
Same author

Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren.

Hamostaseologie·2024
Same author

[Basics for the Use of Andexanet].

Hamostaseologie·2023
Same author

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

[Oncologic aspects in treatment of pathologic fractures].

Der Unfallchirurg·2021
Same author

[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19].

Pneumologie (Stuttgart, Germany)·2021
Same journal

Analysis of the Cost of Maintaining Effective Donors and Nondonors of Organs and Tissues in Intensive Care Units.

Transplantation proceedings·2026
Same journal

Adolescence and Pediatric Heart Transplantation: Impact of Non-Adherence on Mortality: A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Impact of Family-Based Care on the Outcome of Brain Death and Humanization in the Process of Multiple Organ Donation: Case Report.

Transplantation proceedings·2026
Same journal

Karnofsky Performance Status Is Associated with Patient and Graft Survival After Liver Retransplantation.

Transplantation proceedings·2026
Same journal

Evaluating CMV Risk Stratification, Donor Characteristics, and Post-Transplant Outcomes in Kidney Transplant Recipients: A Retrospective Eurotransplant Center Analysis.

Transplantation proceedings·2026
Same journal

Twenty-One Years of Insights From A Single-Center Living Kidney Donation Program.

Transplantation proceedings·2026
See all related articles

Organ preservation solutions like UW and HTK are compared, highlighting UW as the standard but noting its drawbacks. HTK offers a cost-effective alternative for liver and kidney preservation, emphasizing reduced cold ischemia time for better outcomes.

Area of Science:

  • Transplantation immunology
  • Organ preservation solutions
  • Surgical research

Background:

  • Eurocollins solution is largely disused due to glucose-related issues.
  • University of Wisconsin (UW) solution is the established standard for preserving livers, kidneys, and pancreases.
  • UW solution presents challenges including high viscosity, cost, and handling difficulties.

Purpose of the Study:

  • To evaluate alternative organ preservation solutions.
  • To compare the efficacy of UW, HTK, and Celsior solutions.
  • To analyze the impact of cold ischemia time on organ transplant success.

Main Methods:

  • Comparative analysis of existing organ preservation solutions.
  • Review of clinical and experimental data for UW, HTK, and Celsior.

Related Experiment Videos

  • Assessment of cost-effectiveness and handling of preservation solutions.

    • Main Results:

    • HTK solution demonstrates comparable safety and efficacy to UW for liver and kidney preservation within moderate cold ischemia times.
    • HTK offers advantages in terms of lower cost and easier handling.
    • Cold ischemia time is a critical risk factor for organ function, necessitating minimization.

    Conclusions:

    • HTK solution is a viable and potentially more practical alternative to UW for certain organ transplantations.
    • Reducing cold ischemia time is paramount for improving organ transplant outcomes, especially for organs requiring immediate function.
    • Differences in transplant success rates may be attributed to variations in cold ischemia duration rather than inherent organ-specific tolerance.